Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NORTRIPTYLINE Cause Upper respiratory tract infection? 473 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 473 reports of Upper respiratory tract infection have been filed in association with NORTRIPTYLINE (Nortriptyline Hydrochloride). This represents 7.8% of all adverse event reports for NORTRIPTYLINE.

473
Reports of Upper respiratory tract infection with NORTRIPTYLINE
7.8%
of all NORTRIPTYLINE reports
106
Deaths
2
Hospitalizations

How Dangerous Is Upper respiratory tract infection From NORTRIPTYLINE?

Of the 473 reports, 106 (22.4%) resulted in death, 2 (0.4%) required hospitalization, and 3 (0.6%) were considered life-threatening.

Is Upper respiratory tract infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NORTRIPTYLINE. However, 473 reports have been filed with the FAERS database.

What Other Side Effects Does NORTRIPTYLINE Cause?

Drug ineffective (1,128) Off label use (959) Toxicity to various agents (946) Hyperhidrosis (842) Drug hypersensitivity (688) Headache (685) Completed suicide (650) Pain (635) Overdose (633) Fatigue (606)

What Other Drugs Cause Upper respiratory tract infection?

ADALIMUMAB (3,306) ETANERCEPT (2,948) TOFACITINIB (1,805) RITUXIMAB (1,713) ABATACEPT (1,623) METHOTREXATE (1,576) TOCILIZUMAB (1,455) APREMILAST (1,437) PREDNISONE (1,354) SECUKINUMAB (1,339)

Which NORTRIPTYLINE Alternatives Have Lower Upper respiratory tract infection Risk?

NORTRIPTYLINE vs NORVASC NORTRIPTYLINE vs NORVIR NORTRIPTYLINE vs NOSCAPINE NORTRIPTYLINE vs NOVOLOG NORTRIPTYLINE vs NPLATE

Related Pages

NORTRIPTYLINE Full Profile All Upper respiratory tract infection Reports All Drugs Causing Upper respiratory tract infection NORTRIPTYLINE Demographics